Tachykinins and Hematopoiesis

Clinica Chimica Acta

Volumn 385, Issue 1-2, 2007, Pages 28-34

  Liu, Katherine ^a   Castillo, Marianne D ^a   Murthy, Raghav G ^a   Patel, Nitixa ^a   Rameshwar, Pranela ^b  

^a The State University of New Jersey   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Bone marrow; Hematopoiesis; Tachykinins

Indexed keywords

NEUROKININ A; NEUROKININ B; PROTEIN TAC1; SUBSTANCE P; TACHYKININ; TACHYKININ RECEPTOR; UNCLASSIFIED DRUG;

ANEMIA; BLOOD DISEASE; BONE MARROW CELL; BONE MARROW DISEASE; CANCER; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; FIBROSIS; HEART DISEASE; HEMATOPOIESIS; HUMAN; LEUKEMIA; NOCICEPTION; PRIORITY JOURNAL; REVIEW;

ANIMALS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; RECEPTORS, TACHYKININ; TACHYKININS;

EID: 34548483182     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.07.008     Document Type: Review

References (58)

1. Zon L.I. Developmental biology of hematopoiesis. Blood 86 (1995) 2876-2891
2. Weissman I.L. Stem Cells: units of development. Cell 100 (2000) 157-168
3. Kaushansky K., and Karplus A.P. Hematopoietic growth factors: understanding functional diversity in structural terms. Blood 82 (1993) 3229-3240
4. Greco S.J., Corcoran K.E., Cho C.J., and Rameshwar P. Tachykinins in the emerging immune system: relevance to bone marrow homeostasis and maintenance of hematopoietic stem cells. Front Biosci 9 (2004) 1782-1793
5. Novotny G.E.K. Direct innervation of lymphatic organs in the rat. Ann NY Acad Sci 650 (1992) 6-8
6. Felten S.Y., and Felten D.L. Neural-immune interactions. Prog Brain Res 100 (1994) 157-162
7. Weihe E., Nohr D., Michel S., et al. Molecular anatomy of the neuro-immune connection. Int J Neurosci 59 (1991) 1-23
8. Ballieux R.E. Bidirectional communication between the brain and the immune system. Eur J Clin Invest 22 (1992) 6-9
9. Epstein F.H. Neuroendocrine-immune interactions. N Engl J Med 329 (1993) 1246-1253
10. Severini C., Improta G., Falconieri-Erspamer G., Salvadori S., and Erspamer V. The Tachykinin Peptide Family Pharmacological Reviews vol.54 (2002) 285-322
11. Quartara L., and Maggi C.A. The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation. Neuropeptides 31 (1997) 537-563
12. Page N.M., Bell N.J., Gardiner S., Manyonda I.T., Brayley K.J., and Strange P.G. Characterization of the endokinins: human tachykinins with cardiovascular activity. Proc Natl Acad Sci USA 100 (2003) 6245-6250
13. Omar M.A., Irvine G.B., Fitzpatrick G., Glass W.K., and Guthrie D.J.S. Comparative studies on peptides representing the so-called tachykinin-like region of the Alzheimer Ab peptide. Biochem J 336 (1998) 419-427
14. Rameshwar P., and Gascon P. Hematopoietic Modulation by the Tachykinins. Acta Haematologica 98 (1997) 59-64
15. Pennefather J.N., Lecci A., Candenas M.L., Patak E., Pinto F.M., and Maggi C.A. Tachykinins and tachykinin receptors: a growing family. Life Sci 74 (2004) 1445-1463
16. Donnelly D., Maudsley S., Gent J.P., Moser R.N., Hurrell C.R., and Findlay J.B.C. Conserved polar residues in the transmembrane domain of the human tachykinin NK2 receptor: functional roles and structural implications. Biochem J 339 (1999) 55-61
17. Rameshwar P., Poddar A., and Gascón P. Hematopoietic regulation mediated by interactions among the neurokinins and cytokines. Leuk Lymphoma 28 (1997) 1-10
18. Rameshwar P., and Gascon P. Induction of negative hematopoietic regulators by neurokinin-A in bone marrow stroma. Blood 88 (1996) 98-106
19. Page N.M. Characterization of the gene structures, precursor processing and pharmacology of endokinin peptides. Vas Pharmacol 45 (2006) 200-208
20. Bilkei-Gorzo A., Racz I., Michel K., and Zimmer A. Diminished anxiety-and depression-related behaviors in mice with selective deletion of the Tac1 gene. J Neurosci 22 (2002) 10046-10052
21. Kang H.S., Trzaska K.A., Corcoran K., Chang V., and Rameshwar P. Neurokinin receptors: relevance to the emerging immune system. Ach Immunol Ther Exp 52 (2004) 338-347
22. Gao Z., and Peet N.P. Recent advances in neurokinin receptor antagonists. Curr Med Tech 5 (1999) 375-388
23. Quartara L., and Maggi C.A. The tachykinin NK1 receptor. Part II: distribution and pathophysiological roles. Neuropeptides 32 (1998) 1-49
24. Bandari P.S., Qian J., Yehia G., et al. Differences in the expression of neurokinin receptor in neural and bone marrow mesenchymal cells: implications for neuronal expansion from bone marrow cells. Neuropeptides 36 (2001) 13-21
25. Rameshwar P. Substance P: a regulatory neuropeptide for hematopoiesis and immune functions. Clin Immunol Immunopath 85 (1997) 129-133
26. Bandari P.S., Qian J., Oh H.S., et al. Crosstalk between neurokinin receptors is relevant to hematopoietic regulation: cloning and characterization of neurokinin-2 promoter. J Neuroimmunol 138 (2003) 65-75
27. Rameshwar P., Gascon P., Bandari P.S., Joshi D.D., Fernandes A., and Dang A. Structural similarity between the bone marrow extracellular matrix protein and neurokinin 1 could be the limiting factor in the hematopoietic effects of substance P. Can J Physiol Pharm 80 (2002) 475-481
28. Patel H.J., Ramkissoon S.H., Patel P.S., and Rameshwar P. Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides. Proc Natl Acad Sci USA 102 (2005) 17436-17441
29. Zhang Y., Lu L., Furlonger C., Wu G.E., and Paige C.J. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat Immunol 1 (2000) 392-397
30. Manz M.G., Traver D., Miyamoto I., Weissman L., and Akashi K. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood 97 (2001) 3333-3341
31. Morrison S.J., Shah N.M., and Anderson D.J. Regulatory mechanisms in stem cell biology. Cell 88 (1997) 287-298
32. Coa Y.A., Wagers A.J., Beilhack A., Dusich J., Bachmann M.H., and Negrin R.S. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci USA 101 (2004) 221-226
33. Kondo M., Wagers A.J., Manz M.G., et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol 21 (2003) 759-806
34. Deans R.J., and Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol. 28 (2000) 875-884
35. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52 (2000) 595-638
36. Muller-Sieburg C.E., and Deryugina E. The stromal cells' guide to the stem cell universe. Stem Cells 13 (1995) 447-486
37. Minguell J., Erices A., and Conget P. Mesenchymal stem cells. Exp Biol Med 226 (2001) 507-520
38. Lemischka I.R. Microenvironmental regulation of hematopoietic stem cells. Stem Cells 15 (1997) 63-68
39. Santoni G., Amantini C., Lucciarini R., et al. Expression of substance P and its neurokinin-1 receptor on thymocytes: functional relevance in the regulation of thymocyte apoptosis and proliferation. Neuroimmunomodulation 10 (2003) 232-246
40. Rameshwar P., Ganea D., and Gascón P. In vitro stimulatory effect of substance P on hematopoiesis. Blood 81 (1993) 391-398
41. Zhang Y., and Paige C.J. T-cell developmental blockage by tachykinins antagonists and the role of hemokinin 1 in T lymphopoiesis. Blood 102 (2003) 2165-2172
42. Rameshwar P., Gascon P., and Ganea D. Stimulation of interlukin 2 production in murine lymphocytes by substance P and related tachykinins. J Immunol 151 (1993) 2484-2496
43. Gascon P., Qian J., Joshi D.D., Teli T., Haider A., and Rameshwar P. Effects of Preprotachykinin-I Peptides on Hematopoietic Homeostasis. Ann New York Acad Sci 917 (2000) 416-423
44. Rao G., Patel P.S., Idler S.P., et al. Facilitating role of preprotachykinin-I gene in the intergration of breast cancer within the stromal compartment of the bone marrow: a model of early cancer progression. Cancer Res 64 (2004) 2874-2881
45. Fras C., Kravetz P., Mody D.R., and Heggeness M.H. Substance P-containing nerves within the human vertebral body: an immunohistochemical study of the basiverterbral nerve. Spine J 3 (2003) 63-67
46. Tabarowski Z., Gibson-Berry, and Felten S.Y. Noradrenergic and peptidergic innervation of the mouse femur bone marrow. Acta Histochem 98 (1996) 453-457
47. Bianco P., Riminucci M., Gronthos, and Robey P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19 (2001) 180-192
48. Goto T., and Tanaka T. Tachykinins and tachykinin receptors in the bone. Microsc Res Tech 58 (2002) 91-97
49. Goto T., Yamaza T., Mizuho A., Kido M., and Tanaka T. Light and electron-microscopic study of the distribution of axons containing substance P and the localization of neurokinin-1 receptor in bone. Cell Tissue Res 293 (1998) 87-93
50. Afan A.M., Broome C.S., Nicholls S.E., Whetton A.D., and Miyan J.A. Bone marrow innervation regulates cellular retention in the murine haemopoietic system. Br J Haematol 98 (1997) 569-577
51. Palma C. Tachykinins and their receptors in human malignancies. Curr Drug Targets 7 (2006) 1043-1052
52. Barosi G. Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol 17 (1999) 2954-2970
53. Tefferi A. Medical progress: Myelofibrosis with myeloid metaplasia. N Eng J Med 342 (2000) 1255-1265
54. Elliot M.A., and Tefferi A. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review. Blood Rev 13 (1999) 163-170
55. Michiels J.J., Bernema Z., Van Bockstaele D., De Raeve H., and Schroyens W. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF). Pathol Biol 55 (2007) 92-104
56. Oh H.S., Moharita A., Potian J.G., Whitehead I.P., Livingston J.C., and Castro T.A. Bone marrow stroma influences transforming growth factor-B production in breast cancer cells to regulate the c-myc activation of the preprotachykinin-I gene in breast cancer cells. Cancer Res 64 (2004) 6327-6336
57. Maloof P.B., Joshi D.D., Qian J., Gascon P., Singh D., and Rameshwar P. Induction of preprotachykinin-I and neurokinin-1 by adrenocorticotropin and prolactin. Implication for neuroendocrine-immune-hematopoietic axis. J Neuroimmunol 112 (2001) 188-196
58. Nowicki M., and Miskowiak B. Substance P-a potent risk factor in childhood lymphoblastic leukaemia. Leukemia 17 (2003) 1096-1099